vs
Assertio Holdings, Inc.（ASRT）与Laird Superfood, Inc.（LSF）财务数据对比。点击上方公司名可切换其他公司
Assertio Holdings, Inc.的季度营收约是Laird Superfood, Inc.的1.0倍（$13.5M vs $13.3M），Laird Superfood, Inc.同比增速更快（15.0% vs -57.9%），过去两年Laird Superfood, Inc.的营收复合增速更高（16.1% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
Laird Superfood是一家主营植物基功能性超级食品的企业，产品涵盖精品咖啡奶精、补水混合饮品、营养补充剂、植物能量零食等，面向健康意识较强的消费群体，主要在北美市场通过电商及线下零售渠道销售，主打可持续采购的清洁配方。
ASRT vs LSF — 直观对比
营收规模更大
ASRT
是对方的1.0倍
$13.3M
营收增速更快
LSF
高出72.9%
-57.9%
两年增速更快
LSF
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $13.3M |
| 净利润 | — | $-1.8M |
| 毛利率 | — | 34.1% |
| 营业利润率 | -86.7% | -13.5% |
| 净利率 | — | -13.2% |
| 营收同比 | -57.9% | 15.0% |
| 净利润同比 | — | -341.4% |
| 每股收益（稀释后） | $-4.54 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTLSF
| Q4 25 | $13.5M | $13.3M | ||
| Q3 25 | $49.5M | $12.9M | ||
| Q2 25 | $29.2M | $12.0M | ||
| Q1 25 | $26.5M | $11.7M | ||
| Q4 24 | $32.2M | $11.6M | ||
| Q3 24 | $29.2M | $11.8M | ||
| Q2 24 | $31.1M | $10.0M | ||
| Q1 24 | $32.4M | $9.9M |
净利润ASRTLSF
| Q4 25 | — | $-1.8M | ||
| Q3 25 | $11.4M | $-975.1K | ||
| Q2 25 | $-16.4M | $-362.2K | ||
| Q1 25 | $-13.5M | $-156.2K | ||
| Q4 24 | — | $-398.4K | ||
| Q3 24 | $-2.9M | $-166.1K | ||
| Q2 24 | $-3.7M | $-239.1K | ||
| Q1 24 | $-4.5M | $-1.0M |
毛利率ASRTLSF
| Q4 25 | — | 34.1% | ||
| Q3 25 | — | 36.5% | ||
| Q2 25 | — | 39.9% | ||
| Q1 25 | — | 41.9% | ||
| Q4 24 | — | 38.6% | ||
| Q3 24 | — | 43.0% | ||
| Q2 24 | — | 41.8% | ||
| Q1 24 | — | 40.0% |
营业利润率ASRTLSF
| Q4 25 | -86.7% | -13.5% | ||
| Q3 25 | 23.2% | -7.7% | ||
| Q2 25 | -27.5% | -3.3% | ||
| Q1 25 | -50.0% | -1.9% | ||
| Q4 24 | -41.9% | -4.1% | ||
| Q3 24 | -10.4% | -2.3% | ||
| Q2 24 | -11.6% | -3.4% | ||
| Q1 24 | -13.4% | -11.0% |
净利率ASRTLSF
| Q4 25 | — | -13.2% | ||
| Q3 25 | 23.1% | -7.6% | ||
| Q2 25 | -56.0% | -3.0% | ||
| Q1 25 | -51.1% | -1.3% | ||
| Q4 24 | — | -3.4% | ||
| Q3 24 | -10.0% | -1.4% | ||
| Q2 24 | -11.8% | -2.4% | ||
| Q1 24 | -13.9% | -10.3% |
每股收益（稀释后）ASRTLSF
| Q4 25 | $-4.54 | — | ||
| Q3 25 | $0.11 | — | ||
| Q2 25 | $-0.17 | — | ||
| Q1 25 | $-0.14 | — | ||
| Q4 24 | $-3.28 | — | ||
| Q3 24 | $-0.03 | — | ||
| Q2 24 | $-0.04 | — | ||
| Q1 24 | $-0.05 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $5.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $11.5M |
| 总资产 | $267.0M | $19.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASRTLSF
| Q4 25 | $63.4M | $5.1M | ||
| Q3 25 | $93.4M | $5.1M | ||
| Q2 25 | $98.2M | $3.9M | ||
| Q1 25 | $87.3M | $7.0M | ||
| Q4 24 | $100.1M | $8.3M | ||
| Q3 24 | $88.6M | $7.9M | ||
| Q2 24 | $88.4M | $7.6M | ||
| Q1 24 | $80.7M | $7.1M |
总债务ASRTLSF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益ASRTLSF
| Q4 25 | $94.0M | $11.5M | ||
| Q3 25 | $105.8M | $12.8M | ||
| Q2 25 | $93.3M | $13.4M | ||
| Q1 25 | $108.5M | $13.3M | ||
| Q4 24 | $121.1M | $13.2M | ||
| Q3 24 | $130.5M | $13.1M | ||
| Q2 24 | $132.2M | $12.6M | ||
| Q1 24 | $134.5M | $12.7M |
总资产ASRTLSF
| Q4 25 | $267.0M | $19.2M | ||
| Q3 25 | $319.8M | $18.9M | ||
| Q2 25 | $273.8M | $20.4M | ||
| Q1 25 | $286.4M | $21.5M | ||
| Q4 24 | $284.7M | $19.3M | ||
| Q3 24 | $276.0M | $18.8M | ||
| Q2 24 | $279.4M | $18.0M | ||
| Q1 24 | $282.0M | $17.6M |
负债/权益比ASRTLSF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $68.4K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASRTLSF
| Q4 25 | $-30.0M | $68.4K | ||
| Q3 25 | $-4.8M | $1.2M | ||
| Q2 25 | $19.1M | $-2.8M | ||
| Q1 25 | $-12.5M | $-1.3M | ||
| Q4 24 | $11.5M | $339.2K | ||
| Q3 24 | $-35.0K | $305.8K | ||
| Q2 24 | $7.4M | $642.7K | ||
| Q1 24 | $7.5M | $-422.3K |
资本支出强度ASRTLSF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率ASRTLSF
| Q4 25 | — | — | ||
| Q3 25 | -0.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
